Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Lisata Therapeutics (LSTA) Long-Term Debt Issuances (2016 - 2017)

Lisata Therapeutics (LSTA) has disclosed Long-Term Debt Issuances for 8 consecutive years, with $2.0 as the latest value for Q4 2017.

  • For the quarter ending Q4 2017, Long-Term Debt Issuances fell 100.0% year-over-year to $2.0, compared with a TTM value of $2.0 through Sep 2018, down 100.0%, and an annual FY2017 reading of $401000.0, down 50.09% over the prior year.
  • Long-Term Debt Issuances was $2.0 for Q4 2017 at Lisata Therapeutics, down from $400998.0 in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at $13.2 million in Q4 2014 and bottomed at -$221218.0 in Q3 2013.
  • Average Long-Term Debt Issuances over 5 years is $1.3 million, with a median of $382967.0 recorded in 2014.
  • The sharpest move saw Long-Term Debt Issuances skyrocketed 297.17% in 2014, then plummeted 100.52% in 2015.
  • Year by year, Long-Term Debt Issuances stood at -$221218.0 in 2013, then surged by 6077.29% to $13.2 million in 2014, then plummeted by 100.02% to -$2250.0 in 2015, then skyrocketed by 19428.13% to $434883.0 in 2016, then tumbled by 100.0% to $2.0 in 2017.
  • Business Quant data shows Long-Term Debt Issuances for LSTA at $2.0 in Q4 2017, $400998.0 in Q1 2017, and $434883.0 in Q4 2016.